Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BERMUDEZ LE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Roger, PM; Bermudez, LE
      Infection of mice with Mycobacterium avium primes CD8(+) lymphocytes for apoptosis upon exposure to macrophages

      CLINICAL IMMUNOLOGY
    2. Cangelosi, GA; Palermo, CO; Bermudez, LE
      Phenotypic consequences of red-white colony type variation in Mycobacterium avium

      MICROBIOLOGY-UK
    3. Bermudez, LE; Sangari, FJ
      Cellular and molecular mechanisms of internalization of mycobacteria by host cells

      MICROBES AND INFECTION
    4. Young, LS; Bermudez, LE
      Perspective on animal models: Chronic intracellular infections

      CLINICAL INFECTIOUS DISEASES
    5. Limia, A; Sangari, FJ; Wagner, D; Bermudez, LE
      Characterization and expression of secA in Mycobacterium avium

      FEMS MICROBIOLOGY LETTERS
    6. Bermudez, LE; Inderlied, CB; Kolonoski, P; Wu, M; Aralar, P; Young, LS
      Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    7. Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Aralar, P; Wu, M; Young, LS
      Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    8. Mukherjee, S; Petrofsky, M; Yaraei, K; Bermudez, LE; Cangelosi, GA
      The white morphotype of Mycobacterium avium-intracellulare is common in infected humans and virulent in infection models

      JOURNAL OF INFECTIOUS DISEASES
    9. Sangari, FJ; Goodman, J; Petrofsky, M; Kolonoski, P; Bermudez, LE
      Mycobacterium avium invades the intestinal mucosa primarily by interactingwith enterocytes

      INFECTION AND IMMUNITY
    10. McGarvey, JA; Bermudez, LE
      Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition

      INFECTION AND IMMUNITY
    11. Cirillo, SLG; Bermudez, LE; El-Etr, SH; Duhamel, GE; Cirillo, JD
      Legionella pneumophila entry gene rtxA is involved in virulence

      INFECTION AND IMMUNITY
    12. Sangari, FJ; Goodman, J; Bermudez, LE
      Mycobacterium avium enters intestinal epithelial cells through the apical membrane, but not by the basolateral surface, activates small GTPase Rho and, once within epithelial cells, expresses an invasive phenotype

      CELLULAR MICROBIOLOGY
    13. Parker, AE; Bermudez, LE
      Sequence and characterization of the glyceraldehyde-3-phosphate dehydrogenase of Mycobacterium avium: correlation with an epidermal growth factor binding protein

      MICROBIAL PATHOGENESIS
    14. Bodmer, T; Miltner, E; Bermudez, LE
      Mycobacterium avium resists exposure to the acidic conditions of the stomach

      FEMS MICROBIOLOGY LETTERS
    15. Bermudez, LE
      Operation Smile: plastic surgery with few resources

      LANCET
    16. Miltner, EC; Bermudez, LE
      Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    17. Bermudez, LE; Nash, K; Petrofsky, M; Young, LS; Inderlied, CB
      Clarithromycin-resistant Mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    18. Sangari, FJ; Goodman, JR; Bermudez, LE
      Ultrastructural study of Mycobacterium avium infection of HT-29 human intestinal epithelial cells

      JOURNAL OF MEDICAL MICROBIOLOGY
    19. Wu, HS; Kolonoski, P; Chang, YY; Bermudez, LE
      Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice

      INFECTION AND IMMUNITY
    20. Mohagheghpour, N; van Vollenhoven, A; Goodman, J; Bermudez, LE
      Interaction of Mycobacterium avium with human monocyte-derived dendritic cells

      INFECTION AND IMMUNITY
    21. Sangari, FJ; Bermudez, LE
      Nontuberculous mycobacteria

      CYTOKINES IN PULMONARY DISEASE
    22. Petrofsky, M; Bermudez, LE
      Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response

      CLINICAL IMMUNOLOGY
    23. Bermudez, LE; Wu, M; Miltner, E; Inderlied, CB
      Isolation of two subpopulations of Mycobacterium avium within human macrophages

      FEMS MICROBIOLOGY LETTERS
    24. Bermudez, LE; Sangari, FJ; Parker, A
      Green fluorescent protein in the measurement of bacteria-host interactions

      GREEN FLUORESCENT PROTEIN
    25. Bermudez, LE; Kolonoski, P; Wu, M; Aralar, PA; Inderlied, CB; Young, LS
      Mefloquine is active in vitro and in vivo against Mycobacterium avium complex

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    26. Cirillo, JD; Cirillo, SLG; Yan, L; Bermudez, LE; Falkow, S; Tompkins, LS
      Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila

      INFECTION AND IMMUNITY
    27. Bermudez, LE; Goodman, J; Petrofsky, M
      Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice

      INFECTION AND IMMUNITY
    28. Bermudez, LE; Petrofsky, M
      Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells

      INFECTION AND IMMUNITY
    29. Sangari, FJ; Petrofsky, M; Bermudez, LE
      Mycobacterium avium infection of epithelial cells results in inhibition ordelay in the release of interleukin-8 and RANTES

      INFECTION AND IMMUNITY
    30. Bermudez, LE; Parker, A; Petrofsky, M
      Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    31. MADDRY JA; BANSAL N; BERMUDEZ LE; COMBER RN; ORME IM; SULING WJ; WILSON LN; REYNOLDS RC
      HOMOLOGATED AZA ANALOGS OF ARABINOSE AS ANTIMYCOBACTERIAL AGENTS

      Bioorganic & medicinal chemistry letters
    32. BERMUDEZ LE; PETROFSKY M; KOLONOSKI P; YOUNG LS
      EMERGENCE OF MYCOBACTERIUM-AVIUM POPULATIONS RESISTANT TO MACROLIDES DURING EXPERIMENTAL CHEMOTHERAPY

      Antimicrobial agents and chemotherapy
    33. KIM SY; GOODMAN JR; PETROFSKY M; BERMUDEZ LE
      MYCOBACTERIUM-AVIUM INFECTION OF GUT MUCOSA IN MICE ASSOCIATED WITH LATE INFLAMMATORY RESPONSE AND INTESTINAL-CELL NECROSIS

      Journal of Medical Microbiology
    34. BERMUDEZ LE; PETROFSKY M; WU M; YOUNG LS
      CLARITHROMYCIN SIGNIFICANTLY IMPROVES INTERLEUKIN-12-MEDIATED ANTI-MYCOBACTERIUM AVIUM ACTIVITY AND ABOLISHES TOXICITY IN MICE

      The Journal of infectious diseases
    35. KEMPER CA; BERMUDEZ LE; DERESINSKI SC
      IMMUNOMODULATORY TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS BY USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

      The Journal of infectious diseases
    36. BERMUDEZ LE; PETROFSKY M; STEVENS P
      TREATMENT WITH RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIN(TM)) STIMULATES NEUTROPHILS AND TISSUE MACROPHAGES AND INDUCESAN EFFECTIVE NONSPECIFIC RESPONSE AGAINST MYCOBACTERIUM-AVIUM IN MICE

      Immunology
    37. BERMUDEZ LE; INDERLIED CB
      EFFECT OF MYCOBACTERIUM-AVIUM INFECTION ON THE INFLUX, ACCUMULATION, AND EFFLUX OF KRM-1648 BY HUMAN MACROPHAGES

      Microbial drug resistance
    38. PARKER AE; BERMUDEZ LE
      EXPRESSION OF THE GREEN FLUORESCENT PROTEIN (GFP) IN MYCOBACTERIUM-AVIUM AS A TOOL TO STUDY THE INTERACTION BETWEEN MYCOBACTERIA AND HOST-CELLS

      Microbial pathogenesis
    39. BERMUDEZ LE; PETROFSKY M
      REGULATION OF THE EXPRESSION OF MYCOBACTERIUM-AVIUM COMPLEX PROTEINS DIFFERS ACCORDING TO THE ENVIRONMENT WITHIN HOST-CELLS

      Immunology and cell biology
    40. CIRILLO JD; FALKOW S; TOMPKINS LS; BERMUDEZ LE
      INTERACTION OF MYCOBACTERIUM-AVIUM WITH ENVIRONMENTAL AMEBAS ENHANCESVIRULENCE

      Infection and immunity
    41. BERMUDEZ LE; PETROFSKY M; GOODMAN J
      EXPOSURE TO LOW-OXYGEN TENSION AND INCREASED OSMOLARITY ENHANCE THE ABILITY OF MYCOBACTERIUM-AVIUM TO ENTER INTESTINAL EPITHELIAL (HT-29) CELLS

      Infection and immunity
    42. BERMUDEZ LE; PARKER A; GOODMAN JR
      GROWTH WITHIN MACROPHAGES INCREASES THE EFFICIENCY OF MYCOBACTERIUM-AVIUM IN INVADING OTHER MACROPHAGES BY A COMPLEMENT RECEPTOR-INDEPENDENT PATHWAY

      Infection and immunity
    43. AZOUAOU N; PETROFSKY M; YOUNG LS; BERMUDEZ LE
      MYCOBACTERIUM-AVIUM INFECTION IN MICE IS ASSOCIATED WITH TIME-RELATEDEXPRESSION OF TH1 AND TH2 CD4(-LYMPHOCYTE RESPONSE() T)

      Immunology
    44. MOHAGHEGHPOUR N; GAMMON D; VANVOLLENHOVEN A; HORNIG Y; BERMUDEZ LE; YOUNG LS
      MYCOBACTERIUM-AVIUM REDUCES EXPRESSION OF COSTIMULATORY ADHESION MOLECULES BY HUMAN MONOCYTES/

      Cellular immunology
    45. BERMUDEZ LE; PETROFSKY M; STEVENS P
      TREATMENT WITH RECOMBINANT MARINE GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) REDUCES MYCOBACTERIUM-AVIUM INFECTION IN MICE

      Clinical infectious diseases
    46. BERMUDEZ LE; KOLONOSKI P; YOUNG LS
      ROXITHROMYCIN ALONE AND IN COMBINATION WITH EITHER ETHAMBUTOL OR LEVOFLOXACIN FOR DISSEMINATED MYCOBACTERIUM-AVIUM INFECTIONS IN BEIGE MICE

      Antimicrobial agents and chemotherapy
    47. BERMUDEZ LE; INDERLIED CB; KOLONOSKI P; WU M; BARBARABURNHAM L; YOUNG LS
      ACTIVITIES OF BAY-Y-3118, LEVOFLOXACIN, AND OFLOXACIN ALONE OR IN COMBINATION WITH ETHAMBUTOL AGAINST MYCOBACTERIUM-AVIUM COMPLEX IN-VITRO,IN HUMAN MACROPHAGES, AND IN BEIGE MICE

      Antimicrobial agents and chemotherapy
    48. TOJIMBARA T; BERMUDEZ LE; EGAWA H; HAYASHI M; SO SK; ESQUIVEL CO
      CYCLOSPORINE AND TACROLIMUS BOTH SUPPRESS ACTIVATION OF KUPFFER CELLSIN-VITRO

      Transplantation proceedings
    49. BERMUDEZ LE; NASH KA; PETROFSKY M; YOUNG LS; INDERLIED CB
      EFFECT OF ETHAMBUTOL ON EMERGENCE OF CLARITHROMYCIN-RESISTANT MYCOBACTERIUM-AVIUM COMPLEX IN THE BEIGE MOUSE MODEL

      The Journal of infectious diseases
    50. TANTAWICHIEN T; YOUNG LS; BERMUDEZ LE
      INTERLEUKIN-7 INDUCES ANTI-MYCOBACTERIUM AVIUM ACTIVITY IN HUMAN MONOCYTE-DERIVED MACROPHAGES

      The Journal of infectious diseases
    51. BERMUDEZ LE; PETROFSKY M; SHELTON K
      EPIDERMAL GROWTH FACTOR-BINDING PROTEIN IN MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS - A POSSIBLE ROLE IN THE MECHANISM OF INFECTION

      Infection and immunity
    52. BERMUDEZ LE; GOODMAN J
      MYCOBACTERIUM-TUBERCULOSIS INVADES AND REPLICATES WITHIN TYPE-II ALVEOLAR CELLS

      Infection and immunity
    53. FOLEYTHOMAS EM; WHIPPLE DL; BERMUDEZ LE; BARLETTA RG
      PHAGE INFECTION, TRANSFECTION AND TRANSFORMATION OF MYCOBACTERIUM-AVIUM COMPLEX AND MYCOBACTERIUM-PARATUBERCULOSIS

      Microbiology
    54. BERMUDEZ LE; SHELTON K; YOUNG LS
      COMPARISON OF THE ABILITY OF MYCOBACTERIUM-AVIUM, MYCOBACTERIUM-SMEGMATIS AND MYCOBACTERIUM-TUBERCULOSIS TO INVADE AND REPLICATE WITHIN HEP-2 EPITHELIAL-CELLS

      Tubercle and lung disease
    55. BERMUDEZ LE; YOUNG LS
      NEW DRUGS FOR THE THERAPY OF MYCOBACTERIAL INFECTIONS

      Current opinion in infectious diseases
    56. BERMUDEZ LE; KEMPER CA; DERESINSKI SC
      DYSFUNCTIONAL MONOCYTES FROM A PATIENT WITH DISSEMINATED MYCOBACTERIUM-KANSASII INFECTION ARE ACTIVATED IN-VITRO AND IN-VIVO BY GM-CSF

      Biotherapy
    57. BERMUDEZ LE; PETROFSKY M; INDERLIED CB; YOUNG LS
      EFFICACY OF AZITHROMYCIN AND RIFABUTIN IN PREVENTING INFECTION BY MYCOBACTERIUM-AVIUM COMPLEX IN BEIGE MICE

      Journal of antimicrobial chemotherapy
    58. YOUNG LS; BERMUDEZ LE; WU M; INDERLIED CB
      POTENTIAL ROLE OF ROXITHROMYCIN AGAINST THE MYCOBACTERIUM-AVIUM COMPLEX

      Infection
    59. HSU N; YOUNG LS; BERMUDEZ LE
      RESPONSE TO STIMULATION WITH RECOMBINANT CYTOKINES AND SYNTHESIS OF CYTOKINES BY MURINE INTESTINAL MACROPHAGES INFECTED WITH THE MYCOBACTERIUM-AVIUM COMPLEX

      Infection and immunity
    60. BERMUDEZ LE; WU M; YOUNG LS
      INTERLEUKIN-12-STIMULATED NATURAL-KILLER-CELLS CAN ACTIVATE HUMAN MACROPHAGES TO INHIBIT GROWTH OF MYCOBACTERIUM-AVIUM

      Infection and immunity
    61. CHAMPSI J; YOUNG LS; BERMUDEZ LE
      PRODUCTION OF TNF-ALPHA, IL-6 AND TGF-BETA, AND EXPRESSION OF RECEPTORS FOR TNF-ALPHA AND IL-6, DURING MURINE MYCOBACTERIUM-AVIUM INFECTION

      Immunology
    62. BERMUDEZ LE
      IMMUNOBIOLOGY OF MYCOBACTERIUM-AVIUM INFECTION

      European journal of clinical microbiology & infectious diseases
    63. BERMUDEZ LE
      POTENTIAL ROLE OF CYTOKINES IN DISSEMINATED MYCOBACTERIAL INFECTIONS

      European journal of clinical microbiology & infectious diseases
    64. CHAMPSI JH; BERMUDEZ LE; YOUNG LS
      THE ROLE OF CYTOKINES IN MYCOBACTERIAL INFECTION

      Biotherapy
    65. BERMUDEZ LE
      EFFECT OF ETHANOL ON THE INTERACTION BETWEEN THE MACROPHAGE AND MYCOBACTERIUM-AVIUM

      Alcohol
    66. BERMUDEZ LE; SHELTON K
      MYCOBACTERIUM-AVIUM COMPLEX BINDS TO AND INVADES HT-29 AND HEP-2 EPITHELIAL-CELLS

      Journal of cellular biochemistry
    67. BERMUDEZ LE
      USE OF LIPOSOME PREPARATION TO TREAT MYCOBACTERIAL INFECTIONS

      Immunobiology
    68. BERMUDEZ LE; KOLONOSKI P; YOUNG LS; INDERLIED CB
      ACTIVITY OF KRM-1648 ALONE OR IN COMBINATION WITH ETHAMBUTOL OR CLARITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM IN BEIGE MOUSE MODEL OF DISSEMINATED INFECTION

      Antimicrobial agents and chemotherapy
    69. BERMUDEZ LE; YOUNG LS; INDERLIED CB
      RIFABUTIN AND SPARFLOXACIN BUT NOT AZITHROMYCIN INHIBIT BINDING OF MYCOBACTERIUM-AVIUM COMPLEX TO HT-29 INTESTINAL MUCOSAL CELLS

      Antimicrobial agents and chemotherapy
    70. BERMUDEZ LE; INDERLIED CB; KOLONOSKI P; PETROFSKY M; YOUNG LS
      CLARITHROMYCIN, DAPSONE, AND A COMBINATION OF BOTH USED TO TREAT OR PREVENT DISSEMINATED MYCOBACTERIUM-AVIUM INFECTION IN BEIGE MICE

      Antimicrobial agents and chemotherapy
    71. BERMUDEZ LE; MARTINELLI J; PETROFSKY M; KOLONOSKI P; YOUNG LS
      RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ENHANCESTHE EFFECTS OF ANTIBIOTICS AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE BEIGE MOUSE MODEL

      The Journal of infectious diseases
    72. BERMUDEZ LE; YOUNG LS
      FACTORS AFFECTING INVASION OF HT-29 AND HEP-2 EPITHELIAL-CELLS BY ORGANISMS OF THE MYCOBACTERIUM-AVIUM COMPLEX

      Infection and immunity
    73. BYRD SR; GELBER R; BERMUDEZ LE
      ROLES OF SOLUBLE FIBRONECTIN AND BETA-1-INTEGRIN RECEPTORS IN THE BINDING OF MYCOBACTERIUM-LEPRAE TO NASAL EPITHELIAL-CELLS

      Clinical immunology and immunopathology
    74. BERMUDEZ LE; YOUNG LS; MARTINELLI J; PETROFSKY M
      EXPOSURE TO ETHANOL UP-REGULATES THE EXPRESSION OF MYCOBACTERIUM-AVIUM COMPLEX PROTEINS ASSOCIATED WITH BACTERIAL VIRULENCE

      The Journal of infectious diseases
    75. BERMUDEZ LE; CHAMPSI J
      INFECTION WITH MYCOBACTERIUM-AVIUM INDUCES PRODUCTION OF INTERLEUKIN-10 (IL-10), AND ADMINISTRATION OF ANTI-IL-10 ANTIBODY IS ASSOCIATED WITH ENHANCED RESISTANCE TO INFECTION IN MICE

      Infection and immunity
    76. BERMUDEZ LE; COVARO G; REMINGTON J
      INFECTION OF MURINE MACROPHAGES WITH TOXOPLASMA-GONDII IS ASSOCIATED WITH RELEASE OF TRANSFORMING GROWTH-FACTOR-BETA AND DOWN-REGULATION OFEXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS

      Infection and immunity


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 06:28:55